Lundquist Kevin Michael

Insider CIK 2074701 · OTLK Chief Financial Officer

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
OTLK Outlook Therapeutics, Inc.	A Award deriv	2026-09-01	2026-09-02	500,000	—	$0	500,000	SEC↗
OTLK Outlook Therapeutics, Inc.	A Award deriv	2026-09-01	2026-09-02	500,000	—	$0	500,000	SEC↗